drugset / Trial / NCT01737905

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

NCT01737905

Phase 3 Completed 28 enrolled Amphastar Pharmaceuticals, Inc.
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a multi-center, randomized, double-blinded, placebo-controlled, crossover, single dose study in 24 pediatric patients (4-11 years old) with asthma. The entire study consists of (i) a Screening Visit and (ii) a Study Period with two (2) Study Visits. All study subjects must be properly consented, under adult supervision, and screened against the inclusion and exclusion criteria, at the Screening Visit.

Timeline

Start
2012-10
Primary completion
2013-03
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Epinephrine Other / unclassified 125 ug Inhaled

Indications